DAVID WEIR: Open Payments
NPI 1952011397 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 11 payments from 6 companies in 2025. Trend: 2023 $623 · 2024 $55 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 6 | $184 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Medtronic, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: DAXXIFY, REZDIFFRA, Yorvipath, MINIMED 780G, RECORLEV, JARDIANCE.
Industry payments across KY — which companies pay providers there.
